Mixed hematopoietic chimerism at day 90 following allogenic myeloablative stem cell transplantation is a predictor of relapse and survival
収録刊行物
-
- Leukemia
-
Leukemia 18 (10), 1681-1686, 2004-08-19
Springer Science and Business Media LLC